Lilly licenses Alchemab’s ALS antibody ATLX-1282 in $415mn deal, expanding its neuroscience pipeline with a novel, ...

Discover a new study where results suggest that combining systemic and localised treatment can improve tumour control.

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups - read more about the latest trial ...

Understand how ultrasound-guided PDT improves first-puncture success and reduces bleeding risk compared to landmark guidance.

Find out how maternal hypertension affects preterm infant brain development and why early intervention is crucial - read more ...

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Discover a recent study where researchers developed a new evolutionary framework centred on immune robustness. Learn more.

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised ...

A new study shows no survival benefit from adding chemotherapy to radiotherapy in intermediate-risk cervical cancer, ...

In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...

Guselkumab significantly improves clinical remission rates in patients with active ulcerative colitis, according to phase 3 data.

New research highlights the dermatological risks faced by polar explorers, from UV-induced skin cancer to frostbite and ...